SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+6.94%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.32B
AUM Growth
+$1.32B
(-7%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.69%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$33.4M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$25.4M |
| 3 |
Alignment Healthcare
ALHC
|
$23.1M |
| 4 |
Vor Biopharma
VOR
|
$23.1M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$21.9M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$38.5M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$35M |
| 3 |
Labcorp
LH
|
$31.5M |
| 4 |
Exelixis
EXEL
|
$29.6M |
| 5 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$28.3M |
Sector Composition
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Atea Pharmaceuticals
AVIR
$267M
| $82.7M | 6.27% | 1,338,884 -153,206 | -10% | -$9.46M |
|
2
Evolent Health
EVH
$1.12B
| $35.3M | 2.67% | 1,746,638 -301,619 | -15% | -$6.09M |
|
3
Novavax
NVAX
$1.21B
| $34.7M | 2.63% | 191,200 -32,150 | -14% | -$5.83M |
|
|
OCDX
4
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $33.4M | 2.53% | +1,730,500 | New | +$33.4M |
|
5
Teleflex
TFX
$5.59B
| $33.2M | 2.51% | 79,818 -6,375 | -7% | -$2.65M |
|
|
PPD
6
DELISTED
PPD, Inc. Common Stock
PPD
| $32.3M | 2.45% | 852,525 -124,629 | -13% | -$4.72M |
|
7
Arvinas
ARVN
$568M
| $31.1M | 2.36% | 470,042 -62,083 | -12% | -$4.1M |
|
8
AtriCure
ATRC
$1.84B
| $30.8M | 2.33% | 469,867 -174,350 | -27% | -$11.4M |
|
|
RCM
9
DELISTED
R1 RCM Inc. Common Stock
RCM
| $26.4M | 2% | 1,067,768 -106,625 | -9% | -$2.63M |
|
|
10
Arcutis Biotherapeutics
ARQT
$1.86B
| $25.4M | 1.93% | +878,948 | New | +$25.4M |
|
11
TG Therapeutics
TGTX
$4.65B
| $24.8M | 1.88% | 513,649 +307,100 | +149% | +$14.8M |
|
|
TPTX
12
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $24.4M | 1.85% | 257,879 +500 | +0.2% | +$47.3K |
|
13
Repligen
RGEN
$6.88B
| $24.2M | 1.84% | 124,693 +500 | +0.4% | +$97.2K |
|
14
Arcus Biosciences
RCUS
$1.13B
| $24.1M | 1.83% | 859,210 -1,950 | -0.2% | -$54.8K |
|
15
PTC Therapeutics
PTCT
$3.92B
| $23.9M | 1.81% | 504,928 -99,050 | -16% | -$4.69M |
|
|
16
Alignment Healthcare
ALHC
$3.24B
| $23.1M | 1.75% | +1,052,987 | New | +$23.1M |
|
|
17
Vor Biopharma
VOR
$250M
| $23.1M | 1.75% | +535,259 | New | +$23.1M |
|
18
Teladoc Health
TDOC
$1.37B
| $22.7M | 1.72% | 124,713 -85,146 | -41% | -$15.5M |
|
|
ARNA
19
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $22.3M | 1.69% | 321,659 +1,600 | +0.5% | +$111K |
|
|
NVTA
20
DELISTED
Invitae Corporation
NVTA
| $21.9M | 1.66% | +573,759 | New | +$21.9M |
|
|
ACCD
21
DELISTED
Accolade, Inc. Common Stock
ACCD
| $21.4M | 1.62% | +470,750 | New | +$21.4M |
|
|
22
Labcorp
LH
$23.1B
| $20.1M | 1.52% | 78,812 -123,425 | -61% | -$31.5M |
|
23
Rocket Pharmaceuticals
RCKT
$354M
| $19.9M | 1.51% | 447,885 +80,500 | +22% | +$3.57M |
|
24
Zimmer Biomet
ZBH
$21B
| $19.3M | 1.46% | 120,500 -500 | -0.4% | -$80K |
|
|
OSH
25
DELISTED
Oak Street Health, Inc.
OSH
| $19.1M | 1.45% | 351,250 +101,250 | +41% | +$5.49M |
|